Medical Management of Endometriosis

Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endomet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical obstetrics and gynecology 2017-09, Vol.60 (3), p.485-496
Hauptverfasser: RAFIQUE, SAIMA, DECHERNEY, ALAN H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 496
container_issue 3
container_start_page 485
container_title Clinical obstetrics and gynecology
container_volume 60
creator RAFIQUE, SAIMA
DECHERNEY, ALAN H
description Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.
doi_str_mv 10.1097/GRF.0000000000000292
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5794019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1907002741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</originalsourceid><addsrcrecordid>eNp9kE9LAzEQxYMotv75BiIFL162Jtmk2VwEKW0VWgTRc8gms-3q7qYmW4vf3khrqR6cy8DMm_eGH0IXBPcJluJm8jTu4_2ikh6gLuEpTTin-BB141AmkmLSQSchvGJMGBfkGHVoxiVOCe6iqxnY0uiqN9ONnkMNTdtzRW_UWFdD60sXynCGjgpdBTjf9lP0Mh49D--T6ePkYXg3TQynMVRkudWWQs75AOeUEpsDL2heCJ1aSEVqpM20EcxkhbWDwmqwjFFmhaEEBEtP0e3Gd7nKa7Am_uJ1pZa-rLX_VE6X6vemKRdq7j4UF5JhIqPB9dbAu_cVhFbVZTBQVboBtwqKSCwiJ8FIlLKN1HgXgodiF0Ow-uarIl_1l288u9x_cXf0AzQKso1g7aoWfHirVmvwagG6ahf_e38Bt_WHlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1907002741</pqid></control><display><type>article</type><title>Medical Management of Endometriosis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>RAFIQUE, SAIMA ; DECHERNEY, ALAN H</creator><creatorcontrib>RAFIQUE, SAIMA ; DECHERNEY, ALAN H</creatorcontrib><description>Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.</description><identifier>ISSN: 0009-9201</identifier><identifier>EISSN: 1532-5520</identifier><identifier>DOI: 10.1097/GRF.0000000000000292</identifier><identifier>PMID: 28590310</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Angiogenesis Inhibitors - therapeutic use ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Combined Modality Therapy ; Dysmenorrhea - etiology ; Endometriosis - complications ; Endometriosis - drug therapy ; Endometriosis - surgery ; Endometrium - drug effects ; Endometrium - surgery ; Female ; Gonadotropin-Releasing Hormone - therapeutic use ; Hormones - therapeutic use ; Humans ; Pain Management ; Pelvic Pain - etiology ; Treatment Outcome</subject><ispartof>Clinical obstetrics and gynecology, 2017-09, Vol.60 (3), p.485-496</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</citedby><cites>FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28590310$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RAFIQUE, SAIMA</creatorcontrib><creatorcontrib>DECHERNEY, ALAN H</creatorcontrib><title>Medical Management of Endometriosis</title><title>Clinical obstetrics and gynecology</title><addtitle>Clin Obstet Gynecol</addtitle><description>Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.</description><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Dysmenorrhea - etiology</subject><subject>Endometriosis - complications</subject><subject>Endometriosis - drug therapy</subject><subject>Endometriosis - surgery</subject><subject>Endometrium - drug effects</subject><subject>Endometrium - surgery</subject><subject>Female</subject><subject>Gonadotropin-Releasing Hormone - therapeutic use</subject><subject>Hormones - therapeutic use</subject><subject>Humans</subject><subject>Pain Management</subject><subject>Pelvic Pain - etiology</subject><subject>Treatment Outcome</subject><issn>0009-9201</issn><issn>1532-5520</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LAzEQxYMotv75BiIFL162Jtmk2VwEKW0VWgTRc8gms-3q7qYmW4vf3khrqR6cy8DMm_eGH0IXBPcJluJm8jTu4_2ikh6gLuEpTTin-BB141AmkmLSQSchvGJMGBfkGHVoxiVOCe6iqxnY0uiqN9ONnkMNTdtzRW_UWFdD60sXynCGjgpdBTjf9lP0Mh49D--T6ePkYXg3TQynMVRkudWWQs75AOeUEpsDL2heCJ1aSEVqpM20EcxkhbWDwmqwjFFmhaEEBEtP0e3Gd7nKa7Am_uJ1pZa-rLX_VE6X6vemKRdq7j4UF5JhIqPB9dbAu_cVhFbVZTBQVboBtwqKSCwiJ8FIlLKN1HgXgodiF0Ow-uarIl_1l288u9x_cXf0AzQKso1g7aoWfHirVmvwagG6ahf_e38Bt_WHlg</recordid><startdate>201709</startdate><enddate>201709</enddate><creator>RAFIQUE, SAIMA</creator><creator>DECHERNEY, ALAN H</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201709</creationdate><title>Medical Management of Endometriosis</title><author>RAFIQUE, SAIMA ; DECHERNEY, ALAN H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5232-78bdad2eb5560b221dbe5f2bf7a3de373c9d8ac74c8fdd6fdaed4424d7c21e743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Dysmenorrhea - etiology</topic><topic>Endometriosis - complications</topic><topic>Endometriosis - drug therapy</topic><topic>Endometriosis - surgery</topic><topic>Endometrium - drug effects</topic><topic>Endometrium - surgery</topic><topic>Female</topic><topic>Gonadotropin-Releasing Hormone - therapeutic use</topic><topic>Hormones - therapeutic use</topic><topic>Humans</topic><topic>Pain Management</topic><topic>Pelvic Pain - etiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RAFIQUE, SAIMA</creatorcontrib><creatorcontrib>DECHERNEY, ALAN H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RAFIQUE, SAIMA</au><au>DECHERNEY, ALAN H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medical Management of Endometriosis</atitle><jtitle>Clinical obstetrics and gynecology</jtitle><addtitle>Clin Obstet Gynecol</addtitle><date>2017-09</date><risdate>2017</risdate><volume>60</volume><issue>3</issue><spage>485</spage><epage>496</epage><pages>485-496</pages><issn>0009-9201</issn><eissn>1532-5520</eissn><abstract>Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting symptoms. The disease is characterized by estrogen-dependent growth of the endometrial glands and stroma outside the endometrial cavity. The diagnosis requires a high degree of suspicion and can be only confirmed on histopathology. Treatment includes medical and surgical options. Both hormonal and nonhormonal medical options are available and are tried at first with a goal to control pain and stop the growth of the endometriotic lesions. Nonsteroidal anti-inflammatory drugs, oral contraceptive pills, gonadotropin-releasing hormone (GnRH) agonists, aromatase inhibitors are some of the commonly used medications. With more research on the molecular and biochemical aspects of endometriosis, newer targets of therapy are being developed like selective progesterone receptor modulators, antiangiogenic factors and immunomodulators. In women who do not respond to medical therapy or have severe symptoms, surgical excision of the endometrial lesions and adhesions is often helpful and offers confirmatory diagnosis by histopathology.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28590310</pmid><doi>10.1097/GRF.0000000000000292</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9201
ispartof Clinical obstetrics and gynecology, 2017-09, Vol.60 (3), p.485-496
issn 0009-9201
1532-5520
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5794019
source MEDLINE; Journals@Ovid Complete
subjects Angiogenesis Inhibitors - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Combined Modality Therapy
Dysmenorrhea - etiology
Endometriosis - complications
Endometriosis - drug therapy
Endometriosis - surgery
Endometrium - drug effects
Endometrium - surgery
Female
Gonadotropin-Releasing Hormone - therapeutic use
Hormones - therapeutic use
Humans
Pain Management
Pelvic Pain - etiology
Treatment Outcome
title Medical Management of Endometriosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A32%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medical%20Management%20of%20Endometriosis&rft.jtitle=Clinical%20obstetrics%20and%20gynecology&rft.au=RAFIQUE,%20SAIMA&rft.date=2017-09&rft.volume=60&rft.issue=3&rft.spage=485&rft.epage=496&rft.pages=485-496&rft.issn=0009-9201&rft.eissn=1532-5520&rft_id=info:doi/10.1097/GRF.0000000000000292&rft_dat=%3Cproquest_pubme%3E1907002741%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1907002741&rft_id=info:pmid/28590310&rfr_iscdi=true